A novel non-natural nucleoside that influences P-glycoprotein activity and mediates drug resistance

Area of Science:

• Biochemistry
• Pharmacology
• Cancer Research

Background:

• Multidrug resistance (MDR) in cancer chemotherapy is often mediated by P-glycoprotein (P-gp) overexpression.
• P-gp is an ATP-binding cassette transporter responsible for effluxing chemotherapeutic agents.
• Inhibitors targeting P-gp are crucial for overcoming MDR and improving treatment efficacy.

Purpose of the Study:

• To evaluate non-natural nucleosides, mimicking adenosine, as modulators of P-gp activity and MDR.
• To investigate the mechanism by which 5-cyclohexylindolyl-2 '-deoxyribose (5-CHInd) affects P-gp ATPase activity and drug transport.
• To develop a predictive model for P-gp-mediated drug-drug interactions.

Main Methods:

• Synthesis and testing of adenosine analogue nucleosides for P-gp inhibition.
• In vitro assessment of P-gp ATPase activity modulation by 5-CHInd.
• Transport studies using MDCK-MDR1 cell monolayers to evaluate 5-CHInd as a substrate.
• Cytotoxicity assays to determine the effect of 5-CHInd on chemotherapeutic agent efficacy.

Main Results:

• 5-CHInd, a novel nucleoside, unexpectedly stimulates P-gp ATPase activity in vitro, rather than inhibiting it.
• 5-CHInd is not transported by P-gp, indicating it is not an efflux substrate.
• 5-CHInd exhibits variable effects on the cytotoxicity of chemotherapeutic agents, decreasing or increasing it.
• A correlation exists between 5-CHInd-induced changes in ATPase activity and its effect on drug efflux.

Conclusions:

• The paradoxical behavior of 5-CHInd provides a unique tool for understanding P-gp function.
• The study establishes a predictive in vitro model for identifying potential P-gp-mediated drug-drug interactions.
• This research contributes to the development of strategies to combat multidrug resistance in cancer therapy.